What is Digi-prex?
Founded in 2019 and headquartered in San Francisco, California, Digi-Prex operates as a pharmaceutical supplier specializing in home prescription delivery. The company aims to streamline the process of obtaining medications for consumers, positioning itself as a key player in the evolving landscape of healthcare logistics and patient convenience. Its focus on direct-to-consumer delivery addresses a growing market demand for accessible and efficient pharmaceutical services.
How much funding has Digi-prex raised?
Digi-prex has raised a total of $5.5M across 1 funding round:
Angel/Seed
$5.5M
Angel/Seed (2019): $5.5M with participation from Quiet Capital, Y Combinator, Khosla Ventures, Vedanta Capital, and SV Angel
Key Investors in Digi-prex
Y Combinator
Y Combinator, established in 2005, is a renowned seed accelerator providing funding and guidance to early-stage startups, helping them to gauge investors and scale their businesses.
Khosla Ventures
Khosla Ventures, founded in 2004, is a venture capital firm that offers assistance and strategic advice to entrepreneurs focused on breakthrough technologies across various sectors including AI, fintech, and health.
Vedanta Capital
Vedanta Capital specializes in providing access to leading venture capital and growth equity funds, focusing on strategic investment opportunities to empower innovation within the financial landscape.
What's next for Digi-prex?
The recent major strategic investment signals a pivotal moment for Digi-prex, likely enabling the company to scale its operations, enhance its technological infrastructure, and expand its service reach. This infusion of capital is expected to fuel further innovation in its home prescription delivery model, potentially leading to broader market penetration and the development of new service offerings. The company's trajectory suggests a move towards solidifying its position as a leader in the digital pharmaceutical supply chain.
See full Digi-prex company page
